Table 4.
Multivariable Linear Regression Model for 3, 6 and 9 years of follow-up by male and female: Tehran lipids and glucose study
| Male | Female | |||
|---|---|---|---|---|
| β coefficients (95% CI) | P-value | β coefficients (95% CI) | P-value | |
| After 3 years | ||||
| Model 1 | ||||
| Intervention | -0.03 (-0.13-0.07) | 0.529 | -0.10 -0.18–0.02) | 0.016 |
| Model 2 | ||||
| Intervention | -0.03 (-0.12-0.06) | 0.504 | -0.08 (-0.15-0.00) | 0.051 |
| After 6 years | ||||
| Model 1 | ||||
| Intervention | 0.05 [-0.06-0.16) | 0.373 | -0.08 (-0.18-0.02) | 0.106 |
| Model 2 | ||||
| Intervention | 0.04 (-0.06-0.15) | 0.429 | -0.05 (-0.14-0.04) | 0.311 |
| After 9 years | ||||
| Model 1 | ||||
| Intervention | 0.04 (-0.09-0.16) | 0.578 | -0.05 (-0.16-0.06) | 0.375 |
| Model 2 | ||||
| Intervention | 0.03 (-0.09-0.15) | 0.655 | -0.01 (-0.11-0.09) | 0.801 |
T2DM = Type 2 Diabetes
Model 1 adjusted for age and model 2 further adjusted for all possible confounders measured at the baseline including BMI, systolic and diastolic blood pressure, FPG, 2 h-PG, HDL-C, TG, Education levels (≤ 6, 6–12 and > 12 years of education), Low physical activity (< 3 days of performing sports or heavy physical activity per week), current smoking, anti-hypertensive drug use, and Family history of T2DM